Lou X,Qi X,Zhang Y,Long H,Yang J .2013 .Decreased expression of microRNA‐625 is associated with tumor metastasis and poor prognosis in patients with colorectal cancer. J Surg Oncol, 108(4) : 230-5.
White NM,Bao TT,Grigull J,Youssef YM,Girgis A,Diamandis M .2011 .miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. J Urol, 186(3) : 1077-83.
Bouyssou JM,Manier S,Huynh D,Issa S,Roccaro AM .1845 .Ghobrial IM. Regulation of microRNAs in cancer metastasis. Biochim Biophys Acta, : 255-265.
George GP,Mittal RD. .2010 .MicroRNAs: Potential biomarkers in cancer. Indian J Clin Biochem, 25 : 4-14.
Hayes J,Peruzzi PP .2014 .and Lawler S. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med, 20 : 460-9.
Daley GQ .2008 .Common themes of dedifferentiation in somatic cell reprogramming and cancer. Cold Spring Harb Symp Quant Biol, 73 : 171-174.
Huang JJ,Yu J,Li JY,Liu YT,Zhong RQ .2012 .Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma. Med Oncol, 29 : 2402-8.
Si H,Sun X,Chen Y,Cao Y,Chen S,Wang H .2013 .Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer. J Cancer Res Clin Oncol, 139 : 223-9.
Wang M,Li C,Nie H,Lv X,Qu Y,Yu B .2012 .Downregulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK. FEBS Lett, 586 : 2382-8.
Wang Z,Qiao Q,Chen M,Li X,Wang Z,Liu C .2014 .-625 down-regulation promotes proliferation and invasion in esophageal cancer by targeting Sox2. FEBS Lett, 588 : 915-21.
Xu L,Liang YN,Luo XQ,Liu XD,Guo HX .2011 .Association of miRNAs expression profiles with prognosis and relapse in childhood acute lymphoblastic leukemia. Zhonghua Xue Ye Xue Za Zhi, 32(3) : 178-81.
Li C,Li DC,Che SS,Ma K,Wang YJ,Xia LH .2015 .The decreased expression of miR-625 predicts poor prognosis of esophageal squamous cell carcinoma. Int J Clin Exp Med, 8 : 9560-4.
Card DA,Hebbar PB,Li L,Trotter KW,Komatsu Y,Mishina Y .2008 .Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol, 28(20) : 6426-38.
Zhang GM,Bao CY,Wan FN,Cao DL,Qin XJ,Zhang HL .2015 .-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate Cancer. PLoS One, 10(4) : e0124410.
Lin Zhao,Yan Wang,Yu Lifeng .2016 .cooperatively sensitizes breast cancer cells to adriamycin via suppressing P glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1). J Exp Clin Cancer Res, 35 : 25.
Sun S,Zhang G,Wu Z,Shi W,Yang B,Li Y. .2014 .MicroRNA-302a Functions as a Putative Tumor Suppressor in Colon Cancer by Targeting Akt. PLoS One, 9(12) : e115980.
Enver T,Soneji S,Joshi C,Brown J,Iborra F,OrntoftT F .2005 .Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Hum Mol Genet, 14 : 3129-3140.
Sperger JM,Chen X,Draper JS,Antosiewicz JE,Chon CH,Jones SB .2003 .Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci USA, 100 : 13350-13355.
He L,Hannon GJ. .2004 .MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet, 5 : 522-31.
Calin GA,Croce CM .2006 .MicroRNA signatures in human cancers. Nat Rev Cancer, 6 : 857-66.
Fang W,Fan Y,Fa Z,Xu J,Yu H,Li P .2017 .microRNA625 inhibits tumorigenicity by suppressing proliferation, migration and invasion in malignant melanoma. Oncotarget, 8(8) : 13253.
Li BL,Lu W,Lu C,Qu JJ,Yang TT,Yan Q .2013 .CpG island hypermethylation-associated silencing of microRNAs promotes human endometrial cancer. Cancer Cell Int, 13 : 13-44.
Wei JZ,Tao ML,Han GD,Zhu ZC,Miao ZG .2015 .Up-regulation of microRNA-302a inhibited the proliferation and invasion of colorectal cancer cells by regulation of the MAPK and PI3K/Akt signaling pathways. Int J Clin Exp Pathol, 8 : 4481-91.
Guo T,Yu W,Lv S,Zhang C,Tian Y .2015 .-302a inhibits the tumorigenicity of ovarian cancer cells by suppression of SDC1. Int J Clin Exp Pathol, 8 : 4869-80.
Linehan WM .2012 .Genetic basis of kidney cancer: Role of genomics for the development of disease-based therapeutics. Genome Res, 22(11) : 2089-2100.